Improving Rare Disease Diagnosis with Metabolomics
Metabolomics could be a general study of metabolites that are tiny molecules produced by the method of metabolism. The metabolic profile of secretion will give associate degree early outlook of the changes related to a large vary of diseases. It's attainable to measure levels of diseaseâ€specific metabolites exploitation completely different strategies as given during this study. Metabolites, especially when present at atypical levels, can be indicators of rare metabolic diseases. Understanding the implicated metabolic pathways is essential for successful disease diagnosis and treatment.
- Metabolomics for the Screening and Diagnosis of Rare Disease
- Undiagnosed diseases network Metabolomics core
- Integration of clinical metabolomic profiling with interpretation of genetic variants improves diagnosis of rare disease
Related Conference of Improving Rare Disease Diagnosis with Metabolomics
Improving Rare Disease Diagnosis with Metabolomics Conference Speakers
Recommended Sessions
- Clinical Pathology
- Animal and Plant Biochemistry
- Antibody Engineering & Therapeutics
- Biochemistry in Cancer research
- Biomathematics and Biostatistics
- Biophysical techniques
- Biophysics
- Cellular and Molecular Biology
- Clinical & Forensic Biochemistry
- Computational Chemistry and Chemical Biology
- Environmental Biochemistry
- Enzymology and Biochemistry
- Epidemiology
- Food and Nutritional Biochemistry
- Gene Expression and Genetic Engineering
- Improving Rare Disease Diagnosis with Metabolomics
- Industrial & Structural Biochemistry
- Metabolic Biochemistry
- Metabolomic Technology and Bioinformatics
- Metabolomics in Ophthalmology
- Obesity and Metabolic Disorder
- Pharmaceutical Biochemistry
- Protein Engineering
Related Journals
Are you interested in
- 3-D Structure Determination - Structural Biology 2025 (Germany)
- Advancements in structural Biology - Structural Biology 2025 (Germany)
- Biochemistry - Glycobiology 2025 (Germany)
- Biochemistry and Biophysics - Structural Biology 2025 (Germany)
- Computational Approach in Structural Biology - Structural Biology 2025 (Germany)
- Drug Designing and Biomarkers - Structural Biology 2025 (Germany)
- Evolution of Glycan Diversity - Glycobiology 2025 (Germany)
- Frontiers in Structural Biology - Structural Biology 2025 (Germany)
- Gene regulation and Cell Signalling - Structural Biology 2025 (Germany)
- Genomics and Metabolomics - Glycobiology 2025 (Germany)
- Glycans in Diseases and Therapeutics - Glycobiology 2025 (Germany)
- Glycans in Drug Design - Glycobiology 2025 (Germany)
- Glycan’s - Glycobiology 2025 (Germany)
- Glycobiology - Glycobiology 2025 (Germany)
- Glycochemistry - Glycobiology 2025 (Germany)
- Glycoimmunology - Glycobiology 2025 (Germany)
- Glycoinformatics - Glycobiology 2025 (Germany)
- Glycolipids and Glycopeptides - Glycobiology 2025 (Germany)
- Glyconeurobiology - Glycobiology 2025 (Germany)
- Glycopathology - Glycobiology 2025 (Germany)
- Glycosience - Glycobiology 2025 (Germany)
- Hybrid approaches in Structure prediction - Structural Biology 2025 (Germany)
- Molecular Biology - Structural Biology 2025 (Germany)
- Molecular biology techniques - Structural Biology 2025 (Germany)
- Molecular Modelling and Dynamics - Structural Biology 2025 (Germany)
- Proteoglycan and Sialic acid - Glycobiology 2025 (Germany)
- Proteomics and Genomics - Structural Biology 2025 (Germany)
- Recent Advances in Glycobiology - Glycobiology 2025 (Germany)
- Sequencing Analysis - Structural Biology 2025 (Germany)
- Structural Bioinformatics - Structural Biology 2025 (Germany)
- Structural Biology - Structural Biology 2025 (Germany)
- Structural Biology Databases - Structural Biology 2025 (Germany)
- Structural Biology in Cancer Research - Structural Biology 2025 (Germany)
- Structural Enzymology - Structural Biology 2025 (Germany)
- Synthesis and Biological Role of Glycans - Glycobiology 2025 (Germany)